Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2022 | OriginalPaper | Hoofdstuk

21. Psoriasis – meer dan huid alleen

Auteurs: prof. dr. Elke de Jong, dr. Juul van den Reek, dr. Marieke Seyger

Gepubliceerd in: Gendersensitieve huisartsgeneeskunde

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Psoriasis is een chronische, inflammatoire huidziekte die 2–3 % van de populatie treft. Psoriasis is geassocieerd met vele comorbiditeiten, waaronder artritis psoriatica, cardiovasculaire aandoeningen en depressie. Daarnaast kan er sprake zijn van sociale problematiek en wordt de levensloop van patiënten met ernstige vormen op negatieve wijze beïnvloed. Psoriasis wordt gekenmerkt door rode, schilferende plaques die gepaard gaan met jeuk. Op kinderleeftijd kan het klinisch beeld op eczeem lijken. Er zijn veel (nieuwe) effectieve behandelopties voor psoriasis, waaronder biologics en small-molecule inhibitors. Er zijn duidelijke aanwijzingen dat psoriasis bij vrouwen een grotere invloed heeft op hun kwaliteit van leven dan bij mannen. Behandeldoelen lopen eveneens uiteen tussen beide seksen. Vrouwen stoppen vaker met biologics in verband met de bijwerkingen, en zijn minder vaak tevreden over de behandeleffecten. Therapiekeuze rond kinderwens en zwangerschap vraagt maatwerk, voor vrouwen én mannen. Aandacht voor genderspecifieke aspecten bij de behandeling van patiënten met psoriasis is daarom belangrijk.
Literatuur
2.
go back to reference Chen GY, Cheng YW, Wang CY, et al. Prevalence of skin diseases among schoolchildren in Magong, Penghu, Taiwan: a community-based clinical survey. J Formos Med Assoc. 2008;107(1):21–9. CrossRef Chen GY, Cheng YW, Wang CY, et al. Prevalence of skin diseases among schoolchildren in Magong, Penghu, Taiwan: a community-based clinical survey. J Formos Med Assoc. 2008;107(1):21–9. CrossRef
3.
go back to reference Augustin M, Radtke MA, Glaeske G, et al. Epidemiology and comorbidity in children with psoriasis and atopic eczema. Dermatology. 2015;231(1):35–40. CrossRef Augustin M, Radtke MA, Glaeske G, et al. Epidemiology and comorbidity in children with psoriasis and atopic eczema. Dermatology. 2015;231(1):35–40. CrossRef
4.
go back to reference Bronckers IM, Paller AS, Van Geel MJ, Van de Kerkhof PC, Seyger MM. Psoriasis in children and adolescents: diagnosis management and comorbidities. Paediatr Drugs. 2015;17(5):373–84. CrossRef Bronckers IM, Paller AS, Van Geel MJ, Van de Kerkhof PC, Seyger MM. Psoriasis in children and adolescents: diagnosis management and comorbidities. Paediatr Drugs. 2015;17(5):373–84. CrossRef
5.
go back to reference Hagg D, Sundstrom A, Eriksson M, Schmitt-Egenolf M. Severity of psoriasis differs between men and women: a study of the clinical outcome measure psoriasis area and severity index (PASI) in 5438 Swedish Register Patients. Am J Clin Dermatol. 2017;18(4):583–90. CrossRef Hagg D, Sundstrom A, Eriksson M, Schmitt-Egenolf M. Severity of psoriasis differs between men and women: a study of the clinical outcome measure psoriasis area and severity index (PASI) in 5438 Swedish Register Patients. Am J Clin Dermatol. 2017;18(4):583–90. CrossRef
6.
go back to reference Hagg D, Eriksson M, Sundstrom A, Schmitt-Egenolf M. The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men. PLoS One. 2013;8(5):e63619. Hagg D, Eriksson M, Sundstrom A, Schmitt-Egenolf M. The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men. PLoS One. 2013;8(5):e63619.
7.
go back to reference Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13(3):450–6. CrossRef Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13(3):450–6. CrossRef
8.
go back to reference Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945–60. CrossRef Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945–60. CrossRef
10.
go back to reference Ceovic R, Mance M, Bukvic Mokos Z, et al. Psoriasis: female skin changes in various hormonal stages throughout life--puberty, pregnancy, and menopause. Biomed Res Int. 2013;2013:571912. Ceovic R, Mance M, Bukvic Mokos Z, et al. Psoriasis: female skin changes in various hormonal stages throughout life--puberty, pregnancy, and menopause. Biomed Res Int. 2013;2013:571912.
11.
go back to reference Danielsen K, Wilsgaard T, Olsen AO, et al. Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences. Br J Dermatol. 2015;172(2):419–27. CrossRef Danielsen K, Wilsgaard T, Olsen AO, et al. Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences. Br J Dermatol. 2015;172(2):419–27. CrossRef
12.
go back to reference Osier E, Wang AS, Tollefson MM, et al. Pediatric psoriasis comorbidity screening guidelines. JAMA Dermatol. 2017;153(7):698–704. CrossRef Osier E, Wang AS, Tollefson MM, et al. Pediatric psoriasis comorbidity screening guidelines. JAMA Dermatol. 2017;153(7):698–704. CrossRef
13.
go back to reference Wu KK, Armstrong AW. Suicidality among psoriasis patients: a critical evidence synthesis. G Ital Dermatol Venereol. 2019;154(1):56–63. CrossRef Wu KK, Armstrong AW. Suicidality among psoriasis patients: a critical evidence synthesis. G Ital Dermatol Venereol. 2019;154(1):56–63. CrossRef
14.
go back to reference Mabuchi T, Yamaoka H, Kojima T, et al. Psoriasis affects patient’s quality of life more seriously in female than in male in Japan. Tokai J Exp Clin Med. 2012;37(3):84–8. PubMed Mabuchi T, Yamaoka H, Kojima T, et al. Psoriasis affects patient’s quality of life more seriously in female than in male in Japan. Tokai J Exp Clin Med. 2012;37(3):84–8. PubMed
15.
go back to reference Gottlieb AB, Ryan C, Murase JE. Clinical considerations for the management of psoriasis in women. Int J Womens Dermatol. 2019;5(3):141–50. CrossRef Gottlieb AB, Ryan C, Murase JE. Clinical considerations for the management of psoriasis in women. Int J Womens Dermatol. 2019;5(3):141–50. CrossRef
17.
go back to reference Meeuwis KA, De Hullu JA, Van de Nieuwenhof HP, et al. Quality of life and sexual health in patients with genital psoriasis. Br J Dermatol. 2011;164(6):1247–55. CrossRef Meeuwis KA, De Hullu JA, Van de Nieuwenhof HP, et al. Quality of life and sexual health in patients with genital psoriasis. Br J Dermatol. 2011;164(6):1247–55. CrossRef
18.
go back to reference Maul JT, Navarini AA, Sommer R, et al. Gender and age significantly determine patient needs and treatment goals in psoriasis – a lesson for practice. J Eur Acad Dermatol Venereol. 2019;33(4):700–8. CrossRef Maul JT, Navarini AA, Sommer R, et al. Gender and age significantly determine patient needs and treatment goals in psoriasis – a lesson for practice. J Eur Acad Dermatol Venereol. 2019;33(4):700–8. CrossRef
19.
go back to reference Lesuis N, Befrits R, Nyberg F, Van Vollenhoven RF. Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study. BMC Med. 2012;10:82. CrossRef Lesuis N, Befrits R, Nyberg F, Van Vollenhoven RF. Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study. BMC Med. 2012;10:82. CrossRef
20.
go back to reference Nast A, Amelunxen L, Augustin M, et al. S3 Guideline for the treatment of psoriasis vulgaris, update – short version part 1 – systemic treatment. J Dtsch Dermatol Ges. 2018;16(5):645–69. PubMed Nast A, Amelunxen L, Augustin M, et al. S3 Guideline for the treatment of psoriasis vulgaris, update – short version part 1 – systemic treatment. J Dtsch Dermatol Ges. 2018;16(5):645–69. PubMed
21.
go back to reference Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004;140(4):408–14. CrossRef Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004;140(4):408–14. CrossRef
22.
go back to reference Mourad A, Straube S, Armijo-Olivo S, Gniadecki R. Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2019;181(3):450–8. CrossRef Mourad A, Straube S, Armijo-Olivo S, Gniadecki R. Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2019;181(3):450–8. CrossRef
23.
go back to reference Van der Schoot LS, Van den Reek J, Groenewoud JMM, et al. Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registry. J Eur Acad Dermatol Venereol. 2019;33(10):1913–20. CrossRef Van der Schoot LS, Van den Reek J, Groenewoud JMM, et al. Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registry. J Eur Acad Dermatol Venereol. 2019;33(10):1913–20. CrossRef
Metagegevens
Titel
Psoriasis – meer dan huid alleen
Auteurs
prof. dr. Elke de Jong
dr. Juul van den Reek
dr. Marieke Seyger
Copyright
2022
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2707-2_21